Panitumumab
ATC L01FE02 · 10 markets · 19 records
Panitumumab
Forms
AU 5 records · 5 strengths
- 400 mg/20 mLinjectionVectibix
- 100 mg/5 mLinjectionVectibix
- 400 mginjectionVECTIBIX panitumumab 100mg/5mL concentrated injection vial
- 100 mginjectionVECTIBIX panitumumab 100mg/5mL concentrated injection vial
Records without a stated strength · 1 Vectibix
CA 3 records · 1 strengths
- 20 mg/1 mLliquidVectibix
US 2 records · 2 strengths
GB 2 records · 2 strengths
- 400 mg/20 mLinjectionVectibix 100mg/5ml concentrate for solution for infusion vials
- 100 mg/5 mLinjectionVectibix 100mg/5ml concentrate for solution for infusion vials
ES 2 records · 1 strengths
- 20 mginjectionVectibix
SG 1 records · 1 strengths
- 100 mg/vialinjectionVectibix Concentrate for Solution for Infusion 100 mg/vial
TW 1 records · 1 strengths
Records without a stated strength · 1 Vectibix solution for infusion、維必施 注射劑
HK 1 records · 1 strengths
Records without a stated strength · 1 VECTIBIX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Vectibix
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.